查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404818

基於腫瘤的分子診斷市場規模、佔有率和趨勢分析報告：按類型、產品、技術、地區和細分市場預測，2023-2030

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 139 Pages | 商品交期: 2-10個工作天內

價格

基於腫瘤學的分子診斷市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球腫瘤分子診斷市場規模預計將達到60億美元，2023年至2030年複合年成長率為12.1%。

老年人口的增加、全球癌症盛行率的增加、久坐生活方式的普及上升、意識提升和病患教育是預測期內基於腫瘤學的分子診斷市場成長的驅動力。

由於久坐的生活方式和免疫力下降而導致癌症患者數量的增加，預計將提高該行業的成長率。此外，在巴西、墨西哥、南非和印度等新興國家，癌症發病率和死亡率的巨大差異促進了分子診斷的使用，透過早期檢測和檢驗來提高存活率。

基於腫瘤學的分子診斷市場報告亮點

  • 由於高檢測量和豐富的商業化產品組合，乳癌將在 2022 年佔據整個市場的收益佔有率。
  • 由於技術先進的微陣列和檢測方法（例如 miRNA 微陣列）的出現，預計大腸在預測期內將呈現良好的成長趨勢。
  • 以產品分類，試劑業務在 2022 年總收益中所佔佔有率最高，接近 58.0%。研究人員不斷努力檢測用於藥物開發的新型疾病相關生物標記物，估計是該領域成長的主要驅動力。
  • 聚合酶鍊式反應 (PCR) 技術領域的收益佔有率最高，2022 年為 31%。這是由於實驗室的廣泛使用以及對增強診斷的需求不斷成長。
  • 預計定序產業在預測期內將出現 14.3% 的大幅成長。提供高通量分析和基因組資料定序的次世代定序技術的進步是顯著成長的關鍵驅動力之一。
  • 北美地區主導市場，2022 年銷售佔有率超過 40%。該地區市場的強勁成長歸因於其完善的醫療基礎設施、不斷成長的健康意識人口基數以及高昂的醫療成本。
  • 由於目標人口龐大、癌症檢測意識層級不斷提高以及該地區政府措施的增加，亞太地區預計將以 15.8% 的複合年成長率成長最快，並在預測期內實現最大的市場佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章基於腫瘤學的分子診斷市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 基於腫瘤學的分子診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章基於腫瘤的分子診斷市場：類型估計和趨勢分析

  • 基於腫瘤學的分子診斷市場：重點
  • 基於腫瘤學的分子診斷市場：2022 年和 2030 年類型變動和市場佔有率分析
  • 乳癌
    • 2018-2030 年乳癌市場估計與預測
  • 攝護腺癌
    • 2018-2030 年前列腺癌市場估計與預測
  • 大腸直腸癌
    • 2018-2030 年大腸癌市場估計與預測
  • 子宮頸癌
    • 2018-2030 年子宮頸癌市場估計與預測
  • 肝癌
    • 2018-2030 年肝癌市場估計與預測
  • 肺癌
    • 2018-2030 年肺癌市場估計與預測
  • 血癌
    • 2018-2030 年血癌市場估計與預測
  • 腎癌
    • 2018-2030 年腎癌市場估計與預測
  • 其他癌症
    • 2018-2030 年其他癌症市場估計與預測

第5章基於腫瘤的分子診斷市場：產品評估與趨勢分析

  • 基於腫瘤學的分子診斷市場：重點
  • 基於腫瘤學的分子診斷市場：2022 年和 2030 年產品趨勢和市場佔有率分析
  • 裝置
    • 2018-2030 年設備市場估計與預測
  • 試劑
    • 2018-2030 年試劑市場估計與預測
  • 其他
    • 2018-2030 年其他產品的市場估計與預測

第6章基於腫瘤的分子診斷市場：技術評估與趨勢分析

  • 基於腫瘤學的分子診斷市場：重點
  • 基於腫瘤學的分子診斷市場：2022 年和 2030 年技術趨勢和市場佔有率分析
  • PCR
    • 2018-2030 年 PCR 市場估計與預測
  • 原位雜合技術
    • 原位雜合技術市場估計與預測，2018-2030
  • INAAT
    • 2018-2030 年 INAAT 市場估計與預測
  • 晶片微陣列
    • 2018-2030 年晶片/微陣列市場估計與預測
  • 質譜
    • 2018-2030 年質譜市場估計與預測
  • 順序
    • 2018-2030年序列市場估算與預測
  • TMA
    • 2018-2030 年 TMA 市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第7章基於腫瘤的分子診斷市場：區域估計和趨勢分析

  • 區域展望
  • 基於腫瘤學的分子診斷市場（按地區）：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Abbott
    • Bayer AG
    • BD
    • Cepheid
    • Agilent Technologies, Inc.
    • Danaher
    • Hologic, Inc.
    • Qiagen
    • F. Hoffmann-La Roche Ltd.
    • Siemens
    • Sysmex
Product Code: 978-1-68038-699-8

Oncology Based Molecular Diagnostics Market Growth & Trends:

The global oncology based molecular diagnostics market size is expected to reach USD 6.00 billion by 2030, registering a CAGR of 12.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population base, increasing global prevalence of cancer, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the oncology based molecular diagnostics market growth over the forecast period.

Growing prevalence of cancer patients owing to adoption of sedentary lifestyles and decrease in immunity levels are estimated to increase industrial growth rate. Furthermore, large variations in both cancer incidence and mortality rates in different sub-regions of developing countries such as Brazil, Mexico, South Africa, and India are also anticipated to enhance the usage of molecular diagnostics to increase survival rates by early detection and validation.

Oncology Based Molecular Diagnostics Market Report Highlights:

  • Breast cancer dominated the overall market in 2022 in terms of revenue share due to large test volumes and an extensive portfolio of commercialized products.
  • Colorectal cancer is estimated to witness lucrative growth over the forecast period owing to the availability of technologically advanced microarrays & assays such as miRNA microarrays.
  • On the basis of product, the reagents segment held the highest share of almost 58.0% of the overall revenue in 2022. Growing initiatives by researchers in this field for detection of disease related novel biomarkers for drug development purpose are estimated to be the key factors attributing to this segment's growth
  • The polymerase chain reaction (PCR) technology segment held the highest revenue share of 31% in 2022. This can be attributed to its growing utilization in research labs and the increased need for enhanced diagnostics.
  • The sequencing segment is anticipated to witness a significant growth rate of 14.3% during the forecast period. Development of next generation sequencing techniques providing high throughput analysis and sequencing of genomic data is one of the key drivers for significant growth.
  • North America dominated the market with a revenue share of over 40% in 2022 The strong market growth in this region can be attributed to a well-established healthcare infrastructure, the constantly rising health-conscious population base, and high healthcare expenditure.
  • Asia Pacific region is expected to advance at the fastest CAGR of 15.8% during the projection period owing to the presence of a large number of target population, rising awareness levels for cancer detection, and increasing government initiatives in this region enabling the achievement of the largest market share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Technology
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Technology outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Oncology Based Molecular Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Oncology Based Molecular Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Oncology Based Molecular Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 4.2. Oncology Based Molecular Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Breast Cancer
    • 4.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Prostate Cancer
    • 4.4.1. Prostate cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Colorectal Cancer
    • 4.5.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cervical Cancer
    • 4.6.1. Cervical cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Liver Cancer
    • 4.7.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Lung Cancer
    • 4.8.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Blood Cancer
    • 4.9.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Kidney Cancer
    • 4.10.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Other Cancer
    • 4.11.1. Others cancer market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Oncology Based Molecular Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 5.2. Oncology Based Molecular Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Instruments
    • 5.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Reagents
    • 5.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Oncology Based Molecular Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 6.2. Oncology Based Molecular Diagnostics Market: Technology Movement & Market Share Analysis, 2022 & 2030
  • 6.3. PCR
    • 6.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. In situ hybridization
    • 6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. INAAT
    • 6.5.1. INAAT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Chips and microarrays
    • 6.6.1. Chips and microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Mass spectrometry
    • 6.7.1. Mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Sequencing
    • 6.8.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. TMA
    • 6.9.1. TMA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Oncology Based Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Oncology Based Molecular Diagnostics Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. U.K.
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bayer AG
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. BD
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Cepheid
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Agilent Technologies, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Danaher
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Hologic, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Qiagen
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. F. Hoffmann-La Roche Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Sysmex
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 North America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 North America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 Canada Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Canada Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 Europe Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Europe Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Europe Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Germany Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Germany Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Germany Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 UK Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 UK Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 UK Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 France Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 France Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Italy Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Spain Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Spain Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Sweden Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Sweden Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Norway Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Norway Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Norway Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 44 China Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 China Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 46 China Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Japan Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Japan Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Japan Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 India Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 India Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 India Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Thailand Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Thailand Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Thailand Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 South Korea Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Australia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Australia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Latin America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Latin America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 66 Brazil Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Brazil Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Mexico Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Mexico Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 UAE Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 86 UAE Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 UAE Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Oncology based molecular diagnostics market: market outlook
  • Fig. 9 Oncology based molecular diagnostics market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Oncology based molecular diagnostics market driver impact
  • Fig. 15 Oncology based molecular diagnostics market restraint impact
  • Fig. 16 Oncology based molecular diagnostics market strategic initiatives analysis
  • Fig. 17 Oncology based molecular diagnostics market: type movement analysis
  • Fig. 18 Oncology based molecular diagnostics market: type outlook and key takeaways
  • Fig. 19 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cervical cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology based molecular diagnostics market: product movement analysis
  • Fig. 29 Oncology based molecular diagnostics market: product outlook and key takeaways
  • Fig. 30 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oncology based molecular diagnostics market: technology movement analysis
  • Fig. 34 Oncology based molecular diagnostics market: technology outlook and key takeaways
  • Fig. 35 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 INAAT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Chips and microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 TMA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global oncology based molecular diagnostics market: regional movement analysis
  • Fig. 44 Global oncology based molecular diagnostics market: regional outlook and key takeaways
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)